Pharmacological Intervention in Insulin Resistance Targeting Autonomic Nerve Activity

NCT00689208 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Insulin Resistance

Interventions

DRUG: Atropine
DRUG: Physostigmine
DRUG: Placebo Sodium

Sponsor

AstraZeneca